A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery.
Jessica GasparelloChiara PapiMatteo AllegrettiElena GiordaniFabio CarboniSettimio ZazzaEdoardo PescarmonaPaolo RomaniaPatrizio GiacominiChiara ScapoliRoberto GambariAlessia FinottiPublished in: Cancers (2020)
When the data obtained were comparatively evaluated, at least one of the miRNAs belonging to the signature list was found to be dysregulated in 34/35 (97.1%) of our early-CRC plasma samples. The miRNA list provides diagnostic markers as well as possible molecular targets for protocols focusing on "microRNA therapeutics".